SN

Swati Nigam

Active Director Director DIN 01086517
DIN 01086517 First appointment Jan 2007 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2007
Shareholding value •••• Premium profile

About Swati Nigam

Data last updated:

Swati Nigam is a Director at Rickmed Formulations Private Limited (since 2007). The company operates in Chemicals. Rickmed Formulations Private Limited reported revenue of ₹25.4 Lakh (FY 2024).

DIN 01086517
Primary Designation Director
Industry Chemicals
First Appointment 15 Jan 2007
Oldest Company Age 19 yrs
Largest company Rickmed Formulations Private Limited · ₹25.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rickmed Formulations Private Limited U24232MP2007PTC019214
Director15 Jan 20072007₹25.4 Lakh (FY 2024)Active

Board colleagues of Swati Nigam

NameDINCompanyDesignation
Sanjeev Kumar Bamba02496277Rickmed Formulations Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rickmed Formulations Private Limited
Premium access

Shareholding and investment profile for Swati Nigam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Nigam

Swati Nigam currently holds 1 directorship: Rickmed Formulations Private Limited (Director, since 15 Jan 2007, revenue ₹25.4 Lakh (FY 2024)).

Swati Nigam was first appointed on 15 Jan 2007 as Director at Rickmed Formulations Private Limited.

The current boards of Swati Nigam's companies include Sanjeev Kumar Bamba (Rickmed Formulations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available